Check out video highlights of INVEST Precision Medicine conference from pediatrics to funding trends
The INVEST Precision Medicine conference spotlighted the role of children’s hospitals, biopharmaceutical companies, diagnostic companies and startups in biopharmaceutical innovation. The video recordings of the conference sessions are now available for viewing.
Pediatrics and Precision Medicine
A panel of precision medicine experts from pediatric hospitals takes part in a talk highlighting the work being done to improve the way rare diseases and childhood cancers are diagnosed and treated.
Moderator: Samuel Blackman, MD, PhD, Co-Founder and Chief Medical Officer, Day One Biopharmaceuticals
Josh Bonkowsky, MD, PhD, Medical Director, Primary Children’s Center for Personalized Medicine, Intermountain Healthcare Tomi Pastinen, MD, PhD, Director, Genomic Medicine Center, Children’s Mercy Kansas City Peter White, PhD, Senior Director of The Steve & Cindy Rasmussen Institute of Genomic Medicine, Nationwide Children’s Hospital
How can we improve health equity in precision medicine?
Targeted therapies for certain cancers to rare diseases offer new hope for these patient populations. But how can we ensure that these treatments are also developed with minority communities in mind?
Moderator: Kemi Olugemo, MD, Executive Medical Director, Neurology Clinical Development, Ionis Pharmaceuticals, Inc.
Kate Burke, MD, senior medical advisor, PatientsLikeMe
Elisabeth Heath, MD, Associate Center Director, Translational Sciences Chair, Genitourinary Oncology Multidisciplinary Team, Karmanos Cancer Institute
Alyshia Merchant, Founder, Making Lupus Look Good
Software that supports Biopharma R&D
(Sponsored by Komodo Health)
There is a lot of activity in the field of software companies that focus on R&D in the field of cell and gene therapy. This panel explores some of the different approaches companies are taking to improve efficiencies and avoid pitfalls in therapeutic development.
Moderator: John Reites, CEO, THREAD Research
Aswin Chandrakantan, MD, Chief Medical Officer and Head of Life Sciences, Komodo Health Annie Harris, Director of Technology Enablement, Covance
Biologics and the Supply Chain Ballet
The journey from delivering complex therapies to their destination is fraught with pitfalls from the manufacturing process to storing extremely sensitive components in a controlled environment during transport. This panel highlights how different organizations in the biopharmaceutical supply chain are addressing the inherent challenges of manufacturing and delivering cell and gene therapies and biologics.
Moderator: Frank Vinluan, senior reporter, MedCity News
Joe DePinto, Chief Commercial Officer, Vineti Jason Foster, CEO, Ori Biotech Claudia Zylberberg, PhD, Founder and CEO, Akron Biotechnology
The State of Precision Medicine
Precision medicine is gaining ground as more and more providers prescribe genetic testing and more payers decide to reimburse it. In this panel, experts in the field provide a broad overview of where we are and where we need to go to deliver on the promise and potential of precision medicine.
Moderator: Jonathan Hirsch, founder of Syapse
Daniel Knecht, MD, Vice President, Transformation Clinical Product, CVS Health David Spetzler, PhD, President and Chief Scientific Officer, Caris Life Sciences Nephi Walton, MD, Associate Medical Director of Precision Genomics, Intermountain Healthcare
Non-dilutive funding for life sciences startups
A panel discussion on non-dilutive sources of funding for biopharma and medtech startups, from government research and industry grants to industrial partnerships and venture capital.
Moderator: Stephen Nappi, Associate VP for Technology Commercialization and Business Development, Temple University
Tom C.-C. Hu, Ph.D. MBA DABMP, Interdisciplinary Scientist/Project Officer, US Department of Health & Human Services (HHS) Tiffany Wilson, President & CEO, University City Science Center Kelly Wylam, Director of Innovation Partnership, Ben Franklin Technology Partners
Photo: SusanneB, Getty Images